Long term functional and structural outcomes of laser therapy for retinopathy of prematurity by McLoone, Eibhlin et al.
doi:10.1136/bjo.2005.068304 
 2006;90;754-759 Br. J. Ophthalmol.
  
E McLoone, M O’Keefe, S McLoone and B Lanigan 
  
 laser therapy for retinopathy of prematurity
Long term functional and structural outcomes of
 http://bjo.bmjjournals.com/cgi/content/full/90/6/754
Updated information and services can be found at: 
 These include:
 References
  
 http://bjo.bmjjournals.com/cgi/content/full/90/6/754#BIBL
This article cites 22 articles, 8 of which can be accessed free at: 
Rapid responses
 http://bjo.bmjjournals.com/cgi/eletter-submit/90/6/754
You can respond to this article at: 
 service
Email alerting
top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at the
Topic collections
 (2237 articles) Other ophthalmology 
 (634 articles) Vision Research 
 (586 articles) Infants 
  
Articles on similar topics can be found in the following collections 
 Notes   
 http://www.bmjjournals.com/cgi/reprintform
To order reprints of this article go to: 
 http://www.bmjjournals.com/subscriptions/
 go to: British Journal of OphthalmologyTo subscribe to 
 on 7 June 2006 bjo.bmjjournals.comDownloaded from 
EXTENDED REPORT
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Aims: To assess the long term functional and structural outcomes of premature babies who received diode
laser photocoagulation for threshold retinopathy of prematurity (ROP).
Methods: 25 patients (43 eyes) treated with laser were recalled for assessment at a mean follow up of
11 years. A further seven patients (14 eyes) with subthreshold ROP, which had regressed spontaneously
without laser treatment, were also examined. All children underwent distance acuity, near acuity, contrast
sensitivity (CS), and colour vision assessments followed by a dilated fundal examination and cycloplegic
autorefraction.
Results: The laser treated eyes had a mean distance visual acuity of 0.37 logMAR, a mean near visual
acuity of 0.39 logMAR, a mean contrast sensitivity of 1.49 log CS units, and a mean spherical equivalent
of 22.10D. An unfavourable distance visual acuity outcome occurred in five eyes (13.5%). An
unfavourable near visual acuity outcome was also noted in the five eyes (13.5%) with poor distance visual
outcome. 7% had an unfavourable structural outcome. On comparison with the control group, there was
no significant difference in near acuity, CS, refraction, or colour vision between the two groups. However,
there was a statistically significant difference in terms of distance visual acuity (p = 0.03).
Conclusions: Laser treated eyes with favourable structural outcome have a good visual outcome. The
results show a long term benefit from diode laser photocoagulation in preserving distance and near vision
in eyes with threshold ROP.
R
etinopathy of prematurity (ROP) is a potentially blind-
ing condition of premature babies. Ten year follow up
data from the CRYO-ROP study have demonstrated the
long term beneficial effect of cryotherapy on eyes with
threshold ROP.1 2 Laser photocoagulation has replaced
cryotherapy as the established treatment for ROP in most
centres. Although no randomised trial has been conducted on
the scale of the CRYO-ROP study, meta-analysis of smaller
studies has shown laser treatment to be at least as effective as
cryotherapy in the treatment of threshold ROP.3–6
However, there is limited information available on the long
term functional outcome after laser therapy for ROP. The
clinical objective of this study was to evaluate the long term
outcomes of a cohort of premature infants who were treated
with diode laser photocoagulation for threshold ROP. Mean
follow up was 11 years.
METHODS
In all, 41 premature babies who received laser for ROP,
9 years or more previously, were identified from a register of
treated children at the neonatal unit of the National
Maternity Hospital, Dublin. In all cases, laser treatment
was placed, under sedation, anterior to the fibrovascular
ridge in accordance with the Royal College of
Ophthalmologists’ guidelines for ROP treatment.7 Four of
these patients had died before the age of 9 months (deaths
not related to laser treatment). Of the remaining 37 children,
25 were contactable. All were recruited and reviewed with
informed parental consent.
A total of 18 patients, also with 9 years or more of follow
up, were identified as potential controls (at least stage 2, zone
II2III ROP with spontaneous regression) from a logbook of
babies screened for ROP in the neonatal unit (screening
criteria of ,31 weeks gestational age or (1500 g birth
weight). These children were selected for inclusion in the
study with view to having a control population which closely
matched the study population in terms of prematurity and
severity of ROP.8–10 Six of these children were not contactable
and there were five parental refusals. The remaining seven
children participated in the study.
The patients were recalled to the eye clinic at the Children’s
Hospital for assessment by a single observer (EML). For all
measurements of visual function, testing was performed
monocularly with the children wearing their normal specta-
cle correction, where applicable.
Visual acuity
Best corrected distance visual acuity (BCDVA) was recorded
using a back illuminated Distance ETDRS chart (Lighthouse
Inc, New York, NY, USA) at a test distance of 4 metres. Visual
acuity was estimated as the logMAR value of the last line on
which the child could correctly identify three of the five
available letters. In order to include all data in the statistical
analysis, any eye with vision less than 1/60 was assigned a
logMAR score of 2.0.
Best corrected near visual acuity (BCNVA) was recorded
using the Near ETDRS chart (Lighthouse Inc) at the standard
test distance of 40 cm. The procedure and scoring used were
the same as for the distance vision testing.
Contrast sensitivity and colour vision
Contrast sensitivity (CS) was assessed using two Pelli-
Robson charts (one per eye) at a test distance of 1 metre
and estimated as the log contrast value of the last triplet on
which the child identified at least two of the three letters
correctly and also by the total number of letters identified
correctly.11 12
Abbreviations: BCDVA, best corrected distance visual acuity; BCNVA,
best corrected near visual acuity; CS, contrast sensitivity; IVH,
intraventricular haemorrhage; ROP, retinopathy of prematurity
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Colour vision was tested using the HRR pseudoisochro-
matic plates (Richmond Products, Inc, 3rd ed) at a test
distance of 75 cm. There are four demonstration plates and
20 test plates, of which six are screening plates and 14 are
diagnostic plates. For each eye, any incorrect test plates were
noted as well as the corresponding colour defect.
Structural assessment and refraction
After visual function testing, a full eye examination was
conducted including a cover/uncover test, alternate cover test,
extraocular movement assessment, and dilated fundal check
(cyclopentolate 1%). Cycloplegic refraction was performed
using a desktop autorefractometer (Model AR-630A, Nidek
Co Ltd, Japan).
Data analysis
In order to allow comparison of our results with the 10 year
findings of the CRYO-ROP study, we adopted the same
definitions of unfavourable visual and structural outcomes as
used in that study.1 2 An unfavourable distance or near visual
outcome was defined as a Snellen visual acuity of 6/60
(logMAR 1.0) or worse. An unfavourable contrast sensitivity
outcome was defined as a score of 26 letters or less on the
Pelli-Robson chart. An unfavourable structural outcome was
defined as a partial or total retinal detachment involving the
fovea (stage 4b–5), a retinal fold involving the fovea,
retrolental membrane, corneal opacity, or enucleation.
Statistical analysis
Analysis was performed using Matlab 6.5 (Statistics Toolbox
4.0). In order to address any problems with the normality of
the data, continuous outcomes were compared using both the
parametric Student’s t test and the non-parametric Wilcoxon
rank sum test. However, both tests provided consistent
results throughout. Consequently, only Student’s t test p
values are reported in the paper. Fisher’s exact test was used
Table 1 Baseline characteristics of the study population
Variable
Laser group
(25 patients/43 eyes)
Control group
(7 patients/14 eyes)
Laser v control
(p value)
GA (weeks) (mean (SD)) 26.5 (1.7) 27.4 (1.5) 0.21
BW (g) (mean (SD)) 888.8 (184.3) 941.9 (256.6) 0.54
Follow up (years) (mean (SD)) 11.0 (1.0) 11.5 (1.3) 0.29
Sex, n (%)
Male 16 (64) 5 (71) 0.55
Female 9 (36) 2 (29) 0.54
Neurological problems, n (%)
IVH 9 (36) 1 (14) 0.27
ONH 5 (20) 0 (0) 0.26
Sixth nerve palsy 1 (4) 0 (0) 0.78
GA, gestational age; BW, birth weight; SD, standard deviation; IVH, intraventricular haemorrhage; ONH, optic
nerve hypoplasia.
Table 2 Functional outcome of the laser group
Patient Sex
BCDVA
(logMAR)
BCNVA
(logMAR)
Contrast sensitivity
(log CS units)
Spherical equivalent
(D)
Right Left Right Left Right Left Right Left
1*` M 0.3 0.3 0.1 0.0 1.65 1.65 215.00 217.00
2 M – 20.2 – 0.1 – 1.80 – +1.25
3 F 0.0 0.1 0.0 0.1 1.65 1.65 21.38 21.25
4 F 0.9 – 0.4 – 1.20 – 25.63 –
5`1 M 0.4 1.8 0.7 1.6 1.95 0.00 +1.00 24.25
61 M 0.2 1.0 0.1 1.3 1.80 0.90 +0.38 25.75
71 M 20.1 0.4 0.1 0.5 1.80 1.65 +5.13 +2.13
8 F 0.1 0.1 0.0 0.3 1.65 1.65 +0.75 +1.00
9*` M 0.1 – 0.0 – 1.50 – +2.75 –
10 F – 0.0 – 20.1 – 1.65 – 22.88
11 F 0.2 0.4 0.7 0.8 1.65 1.65 +1.25 +0.75
12 M 0.0 0.0 20.1 20.1 1.95 1.80 +1.00 +1.00
13 M 0.0 20.1 0.1 0.0 1.80 1.80 +0.63 +0.63
14 M 0.1 – 0.4 – 1.80 – +1.50 –
15 M 0.8 0.3 0.9 0.3 0.75 1.95 28.25 25.25
16 M – 20.1 – 0.0 – 1.65 – +2.50
17` F 0.1 0.2 0.1 0.1 1.80 1.80 25.50 27.38
18** F 0.0 1.8 0.3 2.0 1.95 0.00 26.25 NA
19 M 0.2 0.2 0.1 0.1 1.65 1.65 26.75 25.50
20` F 0.1 0.2 20.1 20.1 1.80 1.80 20.63 +4.75
21 M – 0.0 – 20.1 – 1.65 – 21.00
22` M 2.0 2.0 2.0 2.0 0.00 0.00 NA NA
GA, gestational age in weeks; BW, birth weight in grams; BCDVA, best corrected distance visual acuity; BCNVA, best corrected near visual acuity; NA, not
available as refraction not possible.
– indicates eyes that did not receive laser treatment as patients had unilateral threshold ROP.
*Optic nerve hypoplasia.
`Intraventricular haemorrhage.
Right eye amblyopic.
1Left eye amblyopic.
Manifest nystagmus of both eyes.
**Patient 18 had a retinal fold involving the left fovea.
Patient 22 had bilateral total retinal detachments.
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to compare categorical outcomes. A p value of less than 0.05
was considered significant.
RESULTS
Of the 25 children in the laser group, 18 had bilateral
treatment and seven had unilateral treatment for threshold
ROP, yielding a total of 43 treated eyes. The control group
comprised seven children (14 eyes). The demographic
characteristics of both groups did not differ significantly
(table 1).
In the laser group, 24 patients (96%) had at least five
contiguous or eight cumulative clock hours of stage 3 disease
in zone II with plus at the time of treatment. Only one patient
(4%) had zone I rush disease in both eyes (that is, ROP in
zone I with plus disease which progressed rapidly within
days). Diode laser treatment was performed at a median
postmenstrual age of 34.6 weeks (range 33.3–40.1 weeks). A
mean of 2.1 laser treatment sessions were required per eye to
achieve regression of ROP.
Structural outcome
Of the 43 laser treated eyes, two eyes (4.7%) progressed to
bilateral total retinal detachments despite diode laser treat-
ment. Both eyes belonged to the one patient who had zone I
rush disease. One eye of another patient was noted to have a
retinal fold involving the fovea. None of the remaining
treated eyes had any evidence of macular ectopia or disc
dragging. Overall, 40 eyes (93%) had a favourable structural
outcome. None of the 14 control eyes with spontaneous
regression of ROP showed any evidence of long term
sequelae.
Eight of the 25 laser patients (32%) had strabismus; four
were convergent and four were divergent. Five patients (20%)
were treated for amblyopia; four of whom had strabismus
and one of whom had myopic anisometropia. Three patients
(12%) were noted to have nystagmus. Of the seven control
patients, one (14.3%) had a convergent squint. None had
amblyopia or nystagmus.
Visual outcome: laser group
Within the laser treated group, three patients with a history
of severe intraventricular haemorrhage (IVH) had severe
cognitive impairment as a result of cerebral palsy and were
unable to cooperate with assessments of visual function. All
three had bilateral optic nerve hypoplasia but otherwise
normal retinal structure. Therefore, data on visual outcome
and refraction were available on 22 patients (37 eyes). This
information is summarised in table 2.
The laser treated eyes had a mean BCDVA of 0.37 logMAR
with 27 eyes (73%) achieving 6/12 or better vision. An
unfavourable distance visual acuity outcome occurred in five
eyes (13.5%). Three of these eyes also had an unfavourable
structural outcome as outlined above. The other two eyes (left
eyes of two patients) were divergent and amblyopic. A
further five eyes (13.5%) also had moderate visual loss (.0.3
to ,1.0 logMAR); three were amblyopic, one had manifest
nystagmus, and one was unexplained.
In terms of near visual acuity, 25 eyes (67.6%) achieved a
Snellen equivalent of 6/12 or better vision with an overall
mean BCNVA of 0.39 logMAR. An unfavourable near vision
outcome was also noted in the five eyes (13.5%) with poor
distance visual outcome (fig 1). Seven eyes (18.9%) had
moderate visual loss. These included the five eyes with
moderate distance visual loss and two others with no obvious
cause for the visual loss.
The mean contrast sensitivity was 1.49 log CS units (32.4
letters correct); 31 eyes (83.8%) read 27 or more letters
correctly on the Pelli-Robson chart and were therefore
considered to have had a favourable outcome. For the overall
data, a strong correlation existed between BCDVA and
contrast sensitivity (r =20.95, p,0.0001). This correlation
was not evident when only those eyes with BCDVA of 0.5
logMAR or better were considered; (r =20.09, p = 0.65).
Fifty per cent of the laser treated eyes were myopic with an
overall mean spherical equivalent of 22.10D.
Visual outcome: comparison with the control group
The control group data on visual outcome and refraction are
given in table 3.
For statistical purposes, only one eye per patient in both
the laser and control groups was included in the comparative
analysis to assess for the effect of the diode laser on visual
outcome. The right eye was chosen in all cases where data
were available for both eyes. One patient in the control group
had grade 1 IVH (subependymal haemorrhage). Higher
grades of IVH have been associated with reduced visual
function.13 14 Therefore, laser treated patients with grade 2 or
more IVH (n = 4) were excluded from the comparative
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Figure 1 Distance and near acuities in laser group.
Table 3 Functional outcome of the control group
Patient Sex
BCDVA
(logMAR)
BCNVA
(logMAR)
Contrast sensitivity
(log CS units)
Spherical equivalent
(D)
Right Left Right Left Right Left Right Left
1 M 20.1 20.1 0.1 0.1 1.95 1.95 +0.88 +0.63
2 F 0.0 0.0 0.2 0.3 1.65 1.80 +7.38 +8.13
3 M 0.0 0.0 20.1 20.1 1.65 1.80 +0.25 +0.13
4 M 20.2 20.2 20.1 20.1 1.80 1.80 +0.25 +0.38
5* M 0.0 0.0 20.1 20.1 1.80 1.65 +1.50 +1.13
6 M 20.1 0.0 0.2 0.1 1.80 1.95 20.63 20.75
7 F 20.2 20.2 20.1 20.1 1.95 1.95 20.25 +0.00
GA, gestational age in weeks; BW, birth weight in grams; BCDVA, best corrected distance visual acuity; BCNVA, best corrected near visual acuity.
*Intraventricular haemorrhage.
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analysis; two of these patients also had ONH and one patient
had bilateral retinal detachments (table 2). As all of the
control eyes had normal fundal structure with no amblyopia
or nystagmus, a further three eyes were also excluded, two
with ambylopia and one with nystagmus. The comparative
data on visual outcome are given in table 4.
Only BCDVA differed significantly between the two groups
(p = 0.03).
Colour vision
Of the 25 children in the laser group, four were unable to
appreciate the HRR demonstration plates (three had severe
cognitive impairment and one had bilateral total retinal
detachments). Only one eye of each the 21 remaining
patients was included in the colour vision analysis. All of
these 21 eyes identified the diagnostic plates correctly.
However, four eyes (19%) failed to correctly identify some
of the symbols on the six screening plates (which are the
most difficult with the lowest saturations) and thus were
considered to have mild colour defects.15 None of the four
children had neurological defects. The class of defect and sex
distribution of the colour deficient children are given in
figure 2. All seven of the children in the control group had
normal colour vision. The observed increase in colour
deficient eyes in the laser group was not statistically
significant (p = 0.29).
DISCUSSION
An ideal control group for this study would consist of patients
with threshold ROP randomised to observation without laser
treatment. However, in light of the unequivocal benefit of
treatment demonstrated in the CRYO-ROP study, this is
obviously unethical.16 In view of this, we selected controls
with significant ROP which failed to reach threshold level
and which regressed spontaneously.
Our comparative visual outcome results showed that the
control group had statistically significant better distance
visual acuity than the laser treated eyes. It is not clear
whether this difference is attributable to a direct effect of the
diode laser itself or to the fact that the control group had less
severe ROP from the outset. It is, however, encouraging to
note that our laser group still performed well in terms of
functional visual acuity. Our overall mean BCDVA of 0.37
logMAR (Snellen equivalent of 20/47) compares favourably
with the findings of other investigators as presented in
table 5.17–19
The mean BCDVA in these studies ranges from approxi-
mately 0.2 to 0.7 logMAR which equates to a five line
difference in reported distance visual outcome. This is partly
attributable to the fact that, as the children were younger at
the time of assessment in some of the other studies, a variety
of methods were employed for distance visual acuity
measurement including Teller acuity cards, HOTV letter
recognition charts, linear tumbling ‘‘E’’ cards, and Snellen
charts. As our study cohort had longer follow up, all of the
patients were old enough to be assessed with the ETDRS
chart. Ng et al also used the ETDRS chart for the majority of
their patients but, compared to our findings, their reduced
mean BCDVA reflects a higher rate of poor structural
outcome in their study.19
While 73% of laser treated eyes achieved 6/12 or better
distance visual acuity, 13.5% had severe visual loss (,6/60)
and a further 13.5% had moderate visual loss (,6/12 but
.6/60). Only three of the 10 eyes with reduced vision had
abnormal structural outcomes. Six eyes with normal fundal
structure had visual loss associated with problems such as
amblyopia, strabismus, and nystagmus, thus emphasising the
importance of long term follow up of these children
regardless of structural outcome. Interestingly, one eye with
normal fundal structure had unexplained reduced distance
vision (0.4 logMAR). Ohlsson et al described similar cases
with unexplained visual loss in a study of 12–13 year old
Swedish children and diagnosed them as having subnormal
visual acuity syndrome.20
Near vision has not previously been documented in eyes
treated with diode laser for threshold ROP. Our laser group
had an overall mean BCNVA of 0.39 logMAR. In the
comparative analysis, the laser group did not differ sig-
nificantly from the control group, suggesting that diode laser
treatment does not adversely affect near visual acuity.
Within the laser treated group, BCDVA worse than 0.5
logMAR was consistently associated with poor contrast
sensitivity. However, a significant correlation between
BCDVA and contrast sensitivity was not evident for those
eyes with BCDVA of 0.5 logMAR or better. As the Pelli-
Robson chart uses letters of low spatial frequency it is
unaffected by mild visual acuity losses and, therefore, may
not have been sensitive enough to detect subtle contrast
sensitivity dysfunction in those eyes with small reductions in
BCDVA.11 It also explains why even in the presence of a
significant difference in terms of distance visual acuity there
was no significant difference in contrast sensitivity between
the modified laser and control groups. In future studies, it
may be more appropriate to use tests such as the functional
acuity contrast test (FACT) which employ several spatial
Table 4 Comparison of functional outcomes
Variable
Modified laser group (15 eyes) Control group (7 eyes)
Laser v
control
Mean SD 95% CI Mean SD 95% CI p value
BCDVA (logMAR) 0.03 0.11 0.06 20.09 0.09 0.08 0.03
BCNVA (logMAR) 0.13 0.23 0.13 0.01 0.15 0.13 0.26
Contrast sensitivity (logMAR) 1.75 0.11 0.06 1.80 0.12 0.11 0.35
Spherical equivalent (dioptres) 20.69 3.37 1.86 +1.34 2.75 2.46 0.18
BCDVA, best corrected distance visual acuity; BCNVA, best corrected near visual acuity.
SD, standard deviation; CI, confidence interval.
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frequencies and are capable of detecting small changes in
contrast sensitivity.21
Fifty per cent of the laser treated eyes were myopic with
35% having more than 4D of myopia. Ospina et al reported
similar results with 62% of their laser treated eyes being
myopic and 48% having more than 4D of myopia.17 Only 21%
of our subthreshold untreated eyes were myopic; all were less
than 21D. As increasing severity of ROP has been shown to
contribute to the development of myopia, it is likely that the
increased myopia in the laser group was the result of the
more severe ROP in these eyes.22 It is not possible from our
study to determine whether the diode laser treatment itself
contributed to the myopia in the treated patients.
Figure 3 compares the unfavourable outcome rate of our
laser treated eyes with the 10 year outcome data from the
CRYO-ROP study.1 2 The data show an overall reduction in
unfavourable outcomes of 69.6% for distance acuity, 68.2%
for near acuity, 59.2% for contrast sensitivity, and 74.3% for
fundus structure in eyes treated with diode laser compared
with eyes treated with cryotherapy for threshold ROP. The
underlying reason for this difference in long term visual
outcome after these two treatments is not clear. We are aware
that this comparative analysis is potentially biased as the
CRYO-ROP eyes are historical controls. Many advances in
perinatal medicine have occurred since the switch to laser
treatment for threshold ROP. These advances may be
responsible for the improved ocular outcomes for severe
ROP rather than the change in treatment. Furthermore, the
CRYO-ROP patients differed from our laser cohort in terms of
mean birth weight (799 (166) g v 889 (184) g, respectively)
although the mean gestational ages of both groups were
similar (26.3 (1.8) weeks v 26.5 (1.7) weeks, respectively).
However, Ng et al also concluded from a randomised
prospective trial of cryotherapy versus laser therapy in eyes
with threshold ROP that laser treated eyes had better
structural and functional outcome compared with eyes
treated with cryotherapy.19 They also noted that eyes which
received cryotherapy were more likely to develop macular
dragging, which was associated with poorer visual acuities,
and speculated that the more widespread nature of the
thermal injury from cryotherapy accounts for the additional
dragging in these patients.
It is interesting that the two eyes which developed stage 5
ROP in our study belonged to a child who had documented
zone I rush disease which progressed despite laser treatment.
Although treatment proved to be efficacious in zone II
threshold disease in the CRYO-ROP study, it was disappoint-
ing in zone I threshold disease with 90% having an
unfavourable outcome.16 23
Our study has several limitations; the numbers are
relatively small, our controls had less severe ROP at outset
and, because of cognitive impairment in three patients, there
was variable participation in the different examinations
performed. While we recognise these limitations, we never-
theless think that this study provides valuable information
regarding the long term benefits of diode laser photocoagula-
tion in the treatment of threshold ROP. At a mean follow up
of 11 years, patients who received diode laser photocoagula-
tion for threshold ROP had a satisfactory visual outcome with
73% of eyes achieving 6/12 or better distance vision and
67.6% achieving 6/12 or better near vision. Only 7% had poor
structural outcome. Laser treated eyes with favourable
structural outcome have a good visual outcome. Our results
show no adverse effect from the diode laser on near vision,
contrast sensitivity, or colour vision.
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